PROTOKINETIX BLOG

Find out how AAGP® is changing lives through cell survival

As we move forward with clinical research for our anti-aging glycopeptide, AAGP®, we continue to uncover new areas of opportunity for the molecule. See how AAGP® is helping to provide more hope for patients and investors in the areas of ophthalmology, transplants, dermatology and biomanufacturing.

Jun 13, 2018

byncaipen

Biomanufacturing

ProtoKinetix' AAGP® Signs a Material Transfer Agreement with a Reputed International Biotech Company

Marietta, Ohio ProtoKinetix, Incorporated (www.protokinetix.com) (the “Company” or “ProtoKinetix”) (OTCQB:PKTX) is pleased to announce that it has executed a Material Transfer Agreement (MTA) with a reputed biotechnology company having a...Read more

Jan 10, 2018

byncaipen

Biomanufacturing | Transplants

ProtoKinetix Has Entered into a Research Agreement with The University of British Columbia to Test the Effect of its AAGP® on Monoclonal Antibody Production and Bone Marrow Recovery

Marietta, Ohio ProtoKinetix, Incorporated (www.protokinetix.com) (the “Company” or “ProtoKinetix”) (OTCQB:PKTX) is pleased to announce that it has entered into a research agreement with The University of British Columbia (UBC), under...Read more

Nov 16, 2017

byncaipen

Biomanufacturing

The Effects of ProtoKinetix' Anti-Aging Glycopeptide (AAGP®) on Immune Cell Banking and Functions Relevant to Immunotherapy

Marietta, Ohio ProtoKinetix, Incorporated (www.protokinetix.com) (the “Company” or “ProtoKinetix”) (OTCQB:PKTX) is pleased to provide a scientific update on immune cell banking and functions relevant to immunotherapy using AAGP® in collaboration...Read more

Oct 17, 2017

byncaipen

Biomanufacturing | Transplants

Scientific Update for Diabetes, Kidney Ischemia, Liver Perfusion, Retinal Cell Replacement, Monoclonal Antibody Production and Immune Cell Cryopreservation Recovery

Belpre, Ohio ProtoKinetix, Incorporated (www.protokinetix.com) (the “Company” or “ProtoKinetix”) (OTCQB:PKTX) is pleased to provide a scientific update to its stockholders. The Company is exploring the following areas for the use...Read more

Jun 05, 2017

byncaipen

Biomanufacturing

ProtoKinetix and Proactive Immune Sciences Announce a Joint Research Collaboration Using AAGP® in Immune Cell Cryopreservation Testing

St. Marys, West Virginia ProtoKinetix, Incorporated (PKTX) (the “Company” or “ProtoKinetix”) (www.protokinetix.com) and Proactive Immune Sciences (www.proactiveimmunesciences.com) today announce that they have entered into a joint research collaboration. The goal of...Read more

Jun 07, 2016

byncaipen

Biomanufacturing | Ophthalmology | Transplants

ProtoKinetix’ AAGP® has been Published in the Journal of Tissue Engineering and Regenerative Medicine

St. Marys, West Virginia ProtoKinetix, Incorporated (OTCQB:PKTX) (the “Company” or “ProtoKinetix”) (www.protokinetix.com) is pleased to announce that a paper submitted by Dr. Kevin Gregory-Evans on ProtoKinetix’ AAGP® has been published...Read more

Request More Information

Talk to a member of the ProtoKinetix team to learn more about our research and results.